CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

Phase 2Foralumabforalumab
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on July 31, 2026 11:00 AM

Read Original